Vancomycin is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Xellia Pharmaceuticals Usa Llc. The primary component is Vancomycin.
Product ID | 70594-043_6509eb92-c2d2-4d5d-bd52-5878f837eb24 |
NDC | 70594-043 |
Product Type | Human Prescription Drug |
Proprietary Name | Vancomycin |
Generic Name | Vancomycin |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2019-02-15 |
Marketing Category | NDA / NDA |
Application Number | NDA211962 |
Labeler Name | Xellia Pharmaceuticals USA LLC |
Substance Name | VANCOMYCIN |
Active Ingredient Strength | 2 g/300mL |
Pharm Classes | Glycopeptide Antibacterial [EPC],Glycopeptides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2019-02-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA211962 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-02-15 |
Marketing Category | NDA |
Application Number | NDA211962 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-02-15 |
Ingredient | Strength |
---|---|
VANCOMYCIN | 1.5 g/300mL |
SPL SET ID: | 60bee69b-be70-412c-9e83-a24a0a8a5e7b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
25021-157 | Vancomycin | vancomycin hydrochloride |
25021-158 | Vancomycin | vancomycin hydrochloride |
70594-040 | Vancomycin | Vancomycin |
70594-041 | Vancomycin | Vancomycin |
70594-042 | Vancomycin | Vancomycin |
70594-043 | Vancomycin | Vancomycin |
70594-044 | Vancomycin | Vancomycin |
70594-056 | Vancomycin | Vancomycin |
70594-057 | Vancomycin | Vancomycin |
70594-058 | Vancomycin | Vancomycin |
51991-940 | Vancomycin Hydrochloride | Vancomycin |
51991-941 | Vancomycin Hydrochloride | Vancomycin |
68001-338 | Vancomycin Hydrochloride | Vancomycin |
68001-339 | Vancomycin Hydrochloride | Vancomycin |